Primary |
Nail Disorder |
50.0% |
Alopecia |
25.0% |
Hair Disorder |
25.0% |
|
Amnesia |
25.0% |
Hair Colour Changes |
25.0% |
Product Quality Issue |
25.0% |
Scan Adrenal Gland Abnormal |
25.0% |
|
Secondary |
Multiple Myeloma |
28.6% |
Drug Use For Unknown Indication |
12.7% |
Product Used For Unknown Indication |
10.1% |
Vitamin Supplementation |
10.1% |
Tonic Convulsion |
6.9% |
Hypertension |
6.3% |
Blood Cholesterol Increased |
4.2% |
Osteoporosis |
2.6% |
Blood Pressure High |
2.1% |
Cardiac Disorder |
2.1% |
High Cholesterol |
2.1% |
Ankle Swelling |
1.6% |
Diabetes Mellitus |
1.6% |
Hiv Infection |
1.6% |
Supplementation Therapy |
1.6% |
Urticaria |
1.6% |
Atrial Fibrillation |
1.1% |
Blood Lactate Dehydrogenase Decreased |
1.1% |
Hair Disorder |
1.1% |
Hyperparathyroidism Secondary |
1.1% |
|
Visual Impairment |
14.3% |
Vitreous Floaters |
14.3% |
Clostridium Difficile Colitis |
8.6% |
Blindness Transient |
5.7% |
Intervertebral Disc Protrusion |
5.7% |
Loss Of Consciousness |
5.7% |
Mucosal Inflammation |
5.7% |
Self-medication |
5.7% |
Abdominal Distension |
2.9% |
Alopecia |
2.9% |
Cardiac Arrest |
2.9% |
Cardiomegaly |
2.9% |
Chest Pain |
2.9% |
Coombs Direct Test Positive |
2.9% |
Diarrhoea |
2.9% |
Drug Hypersensitivity |
2.9% |
Engraftment Syndrome |
2.9% |
Head Injury |
2.9% |
Hypersomnia |
2.9% |
Hypertension |
2.9% |
|
Concomitant |
Product Used For Unknown Indication |
43.3% |
Drug Use For Unknown Indication |
9.1% |
Rheumatoid Arthritis |
5.9% |
Vitamin Supplementation |
4.8% |
Prophylaxis |
4.1% |
Supplementation Therapy |
4.0% |
Hypertension |
3.7% |
Pain |
2.6% |
Osteoporosis |
2.6% |
Crohn's Disease |
2.4% |
Depression |
2.4% |
Gastrooesophageal Reflux Disease |
2.3% |
Blood Cholesterol Increased |
2.0% |
Asthma |
1.8% |
Atrial Fibrillation |
1.7% |
Alopecia |
1.7% |
Multiple Sclerosis |
1.7% |
Anxiety |
1.4% |
Diabetes Mellitus |
1.4% |
Hypothyroidism |
1.4% |
|
Weight Increased |
11.2% |
Vomiting |
9.4% |
Pruritus |
7.5% |
Drug Ineffective |
6.6% |
Alopecia |
6.4% |
Rash |
5.7% |
Weight Decreased |
5.0% |
Nausea |
4.6% |
Pain |
4.4% |
Pain In Extremity |
4.4% |
Injection Site Pain |
4.2% |
Pulmonary Embolism |
3.9% |
Sinusitis |
3.9% |
Headache |
3.7% |
Urticaria |
3.5% |
Flushing |
3.3% |
Convulsion |
3.1% |
Pyrexia |
3.1% |
Somnolence |
3.1% |
Vision Blurred |
3.1% |
|
Interacting |
Product Used For Unknown Indication |
63.2% |
Joint Swelling |
10.5% |
Blood Cholesterol Abnormal |
5.3% |
Blood Cholesterol Increased |
5.3% |
Blood Pressure Abnormal |
5.3% |
Constipation |
5.3% |
Hypertension |
5.3% |
|
Road Traffic Accident |
33.3% |
Drug Interaction |
16.7% |
Loss Of Consciousness |
16.7% |
Somnolence |
16.7% |
Syncope |
16.7% |
|